Stock Market Reviews

Read and share opinions on SBFM (Sunshine Biopharma, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
  Oct 28, 2025
• Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
  Oct 28, 2025
• Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
  Oct 20, 2025
• Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
  Oct 16, 2025
• Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
  Oct 14, 2025
• Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)
  Oct 14, 2025
• Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience
  Oct 14, 2025
• Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
  Oct 9, 2025
• Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market
  Jul 2, 2025
• Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market
  Jun 11, 2025
• Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year
  May 15, 2025
• Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market
  May 6, 2025
• Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
  Apr 21, 2025
• Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
  Apr 3, 2025
• Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
  Apr 2, 2025
• Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer
  Apr 2, 2025
• Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year
  Apr 1, 2025
• Sunshine Biopharma signs agreement for rights to market two generic antibiotics
  Mar 25, 2025
• Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada
  Mar 24, 2025
• Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market
  Mar 10, 2025